Jim Cramer Reveals AbbVie’s (ABBV) “Good Stuff”
Yahoo News
Last updated: May 15, 2026
Jim Cramer, host of CNBC's "Mad Money," shared his primary concern regarding artificial intelligence (AI) investments and highlighted twenty specific stocks he discussed. Among these was pharmaceutical company AbbVie Inc.
- Cramer's main apprehension about AI investments centers on the potential for overvaluation and the difficulty in discerning truly innovative companies from those merely capitalizing on the AI trend. He expressed concern that the rapid influx of capital into AI could lead to a bubble.
- Among the twenty stocks mentioned, AbbVie Inc. (NYSE:ABBV) was specifically identified. While the provided text does not detail Cramer's specific rationale for including AbbVie or his outlook on the company, it confirms its inclusion in his discussion of AI-adjacent or relevant investment opportunities. The broader context suggests Cramer is navigating the current market excitement around AI, seeking to identify solid companies amidst the hype.
